Delivery Order SPE2DB22D1002-SPE2DB23FLGR1
- Not listed
- The Defense Logistics Agency (DLA) awarded a $31,675.49 firm fixed price delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100mg tablets (100 count). This contract, awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a pharmaceutical supply delivery under a non-set-aside competitive procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets (100-count units) valued at $2,350.53 under a firm fixed price contract. This antimalarial pharmaceutical product is being delivered to support military healthcare requirements, with the place of performance located in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $7,718.44 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Atovaquone-Proguanil 250-100mg in quantities of 100 tablets. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The work will be...
- The Defense Logistics Agency awarded a delivery order valued at $22,857.87 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100mg tablets (100 count). This competitive, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of July 21, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. The medication is an...
- The Defense Logistics Agency awarded a $2,248.56 delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 tablets (100-count supply). The contract, which is firm fixed price with no set-aside designation, was awarded on August 18, 2025, and is scheduled for completion by August 19, 2025. Performance will be executed at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $33,579 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 in a quantity of 100 units. The contract, which was competitively awarded without set-aside designation, has an ultimate completion date of September 17, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $4,599.31 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets in quantities of 100. This is a firm fixed-price delivery order with an ultimate completion date of July 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation and was competitively awarded. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at ten thousand three hundred fifty-two dollars and eighty-five cents ($10,352.85) to Amerisourcebergen Drug Corporation for the provision of 4562127391 units of atovaquone-proguanil anti-malarial tablets. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania under a September 11-12, 2023 period of performance. As a major distributor supporting the Defense Logistics Agency's medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,245.97 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100 (100 tablets), a antimalarial medication used primarily for malaria prophylaxis and treatment in military personnel. The contract was awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, under firm fixed price terms with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $25,275.80 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100 tablets (100-count units) with a completion date of June 2, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical product will be delivered to the vendor's corporate office location in...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB23FLGR1Delivery Order
The Defense Logistics Agency awarded a $25,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Atovaquone-Proguanil tablets. Under this contract, Amerisourcebergen will deliver 250-100mg units of the antimalarial drug to a location in Conshohocken, Pennsylvania by September 25, 2023. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing DLA-wide contract vehicle. The prime contractor, Amerisourcebergen Drug Corporation, will perform the order without involvement of major subcontractors. As the DLA's mission involves supplying the U.S. military globally, this contract supports the agency's efforts to provide critical pharmaceuticals to troops.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.0k | 9/22/23 |